PhaseBio Pharmaceuticals Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 16:03

PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence